Chlorambucil

苯丁酸氮芥

Report date: 2023/05/05 17:34:42
NME

Base Information

Drug NameChlorambucil
Drug Alias Name苯丁酸掞芥氯芥苯丁酸留可然LeukeranGR-64465 +[8
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA synthesis inhibitors
TargetsNot applicable
Therapy Area/IndicationsOvarian NeoplasmsBreast NeoplasmsWaldenstrom Macroglobulinemia +[10
Global Approved IndicationsOvarian NeoplasmsBreast NeoplasmsWaldenstrom Macroglobulinemia +[9
Approved Indications in ChinaOvarian NeoplasmsBreast NeoplasmsWaldenstrom Macroglobulinemia +[6
Original Approved Country/TerritoryUnited States
Original Approved Date1957/03/18
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAspen Pharma
China Registration ClassN/A

Develop Information

Inactive CompaniesGlaxosmithkline Plc
Active IndicationsOvarian NeoplasmsBreast NeoplasmsWaldenstrom Macroglobulinemia +[9
Inactive IndicationsLeukemia, Lymphoid

Other Information

ATC CodeL01AA02